Skip to contentNew · Nine works, each built from one design.md

Work 07 of 9 · Playbook H

Aster Bio

Engineering cellular resilience against age-related disease.

Playbook
H · Deep tech & science
Variant
H · Organic science
Loud idea
Tri-color full-bleed pillars
Type
Manrope 400 · Manrope 400 · Geist Mono
Preview width
Open the full page
Aster Bio

Preclinical biotech

Engineering cellular resilience against age-related disease.

Small molecules that restore how aged cells respond to stress. Our lead program, AST-201, begins IND-enabling studies in 2027.

Explore the platform

Platform

Three steps from aging biology to a medicine.

We start from human aging data, not a single target. Every program moves through the same three stages, in this order.

  1. Cellular atlas

    We profile 2.4 million aged human cells across 14 tissues to find where stress responses fail first.

  2. Molecule design

    A structure-guided chemistry platform designs small molecules that restore those responses, and only those.

  3. Translational models

    Candidates are tested in human organoids and aged mouse cohorts before a single patient is dosed.

Publications

Peer-reviewed, and published in full.

Our datasets and methods go out with every paper, so other labs can check the work.

  • Peer-reviewed

    A small-molecule eIF2B activator restores stress recovery in aged human fibroblasts

    Aging Mechanisms · Okonkwo R, Lindqvist M, Rao P, et al.

    doi:10.5555/ast.2026.0806
  • Peer-reviewed

    A single-cell atlas of stress-response decline across 14 human tissues

    Cell Resilience Reports · Rao P, Adeyemi K, Moreau L, et al.

    doi:10.5555/ast.2026.0318
  • Preprint

    AST-201 preserves cardiac function in 24-month-old mice without weight loss

    Molecular Gerontology Letters · Lindqvist M, Hart E, Chen Y, et al.

    doi:10.5555/ast.2025.1120

Resilient cells, healthier decades.

Work with us

Hiring medicinal chemists and computational biologists.

careers@aster.bio

Labs

Cambridge, MA
London, UK

© 2026 Aster Biosciences, Inc.

Aster Bio is fictional; this page is a 71UI study.

Brief

What it had to do.

Subject
A biotech developing small-molecule therapeutics for aging.
Audience
Scientists, investors and prospective hires.
Job
Understand the platform, then work with the team.
Proof
Named programs, publications and a clear pipeline.

Token plan

Written before any code.

design.md’s Agent Protocol asks for this table first. Ratios are WCAG 2, measured on the surface each color actually sits on.

ColorHexRoleContrast
Off-white#F7F7F5Page
Charcoal#222F30Ink, primary12.90:1
Body#50595ABody text6.71:1
Sage dim#8A8D7EHeadline tail, ≥ 24px only3.16:1
Soft mint#CEF79EPillar, arrow tiles11.48:1 with ink
Stone#E7E8E1Pillar

Decisions

Why it looks this way.

  1. 01

    Weight 400 everywhere at −0.02em; hierarchy comes from size alone, as on Integrated Bio.

  2. 02

    The three full-bleed pillars are the loud idea; the split CTA and notched cards use their quiet fallbacks.

  3. 03

    The dimmed headline tail is #8A8D7E (3.16:1 at ≥ 24px) — the reference's #C9CBBE measures 1.53:1.

  4. 04

    Mono uppercase labels mark real categories and dates only, one per section.